You are not logged in
You need to be a member to print this page.
Sign up for free membership, or log in.
Find out more about our membership benefits
News and views
Br J Cardiol 2011;18:203
Changes to hypertension guidelines
The National Institute for Health and Clinical Excellence (NICE) has updated its guideline on hypertension, making a number of new recommendations regarding both the diagnosis...
Br J Cardiol 2011;18:203
Dronedarone to be restricted
The European Medicines Agency has recommended that the anti-arrhythmic, dronedarone (Multaq®), should be...
Br J Cardiol 2011;18:203
Rivaroxaban reduces events in ATLAS-ACS
Bayer has announced that the oral anticoagulant, rivaroxaban, has reduced ischaemic events but increased bleeding in acute coronary syndrome (ACS) patients in the large-scale trial...
Br J Cardiol 2011;18:208–210
News from the ESC Congress 2011
Highlights of the European Society of Cardiology (ESC) 2011 Congress, held in Paris, France, from 27th–31st August, included encouraging results with the third new oral...
Br J Cardiol 2011;18:212-213
Quality in CVD care – taking the lead in the new NHS
This year’s 14th Annual Scientific Meeting of the Primary Care Cardiovascular Society (PCCS), held in Bristol, 28th–30th September 2011, highlighted the controversial reforms in the...
Br J Cardiol 2011;18:214-215
Is it a bird? Is it a plane? No, it’s radial man!
We continue our series in which Consultant Interventionist Dr Michael Norell takes a sideways look at life in the cath lab…and beyond. In this column,...
Br J Cardiol 2011;18:153-154